GLAXOSMITHKLINE PHARMA LT (GLAXO)

NSE: ₹2,166.60
BSE: ₹2,166.50
Stock Performance
Corporate Announcements
2026-06-08 11:42:04
AGM Notice For 2025-26

As per attachment

2026-06-05 19:49:40
2026-06-05 19:48:19
Reg. 34 (1) Annual Report.

Annual Report for 2025-26

2026-06-05 19:45:09
Announcement under Regulation 30 (LODR)-Change in Management

Resignation of Dr. Simrat Sohal as Compliance officer of the Company

2026-05-29 12:38:56
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Compliance Secretarial Report for year ended March 2026

2026-05-26 10:24:56

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 761.66 956.99 805.26 929.80 814.65 1,010.77 949.42 974.37 805.17 979.94 1,041.26 995.30
YOY Revenue Growth % 2.22% 4.38% 0.37% 18.08% 6.96% 5.62% 17.9% 4.79% -1.16% -3.05% 9.67% 2.15%
Other Income 36.44 28.21 28.11 29.83 35.64 34.54 35.07 40.68 43.72 33.57 32.12 35.95
Total Income 798.10 985.20 833.37 959.63 850.29 1,045.31 984.49 1,015.05 848.89 1,013.51 1,073.38 1,031.25
Total Expenses + 634.42 686.04 604.63 691.41 600.89 706.19 676.39 656.48 569.91 662.15 691.43 658.15
Cost of Materials Consumed 158.41 91.21 90.95 204.60 138.23 148.96 97.48 115.23 128.06 115.13 79.90 113.06
Employee Benefit Expense 165.00 145.21 141.35 172.83 151.28 150.71 124.74 152.97 152.57 138.05 151.88 164.75
Other Expenses 156.66 167.85 129.01 132.58 137.56 153.86 173.60 136.27 113.69 150.63 154.22 135.62
Operating Profit 127.24 270.95 200.63 238.39 213.76 304.58 273.03 317.89 235.26 317.79 349.83 337.15
OPM % 16.7% 28.3% 24.9% 25.6% 26.2% 30.1% 28.8% 32.6% 29.2% 32.4% 33.6% 33.9%
Profit Before Tax + 180.98 299.16 65.43 270.62 249.40 343.81 308.10 358.57 278.98 354.00 399.93 373.10
Tax Expense 48.73 81.65 19.71 76.14 67.07 91.31 78.22 95.70 73.97 96.51 104.31 95.24
Tax % 26.9% 27.3% 30.1% 28.1% 26.9% 26.6% 25.4% 26.7% 26.5% 27.3% 26.1% 25.5%
Profit After Tax 132.25 217.51 45.72 194.48 182.33 252.50 229.88 262.87 205.01 257.49 295.62 277.86
EPS (Basic) 7.04 12.84 9.89 11.48 10.76 14.67 13.57 15.52 12.10 15.07 16.54 16.40

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 3,821.67 3,749.21 3,453.71 3,251.72 3,278.03 3,198.86 3,224.38
YOY Revenue Growth % 1.93% 8.56% 6.21% -0.8% 2.47% -0.79% -
Other Income 145.36 145.93 122.59 100.66 75.78 110.58 79.01
Total Income 3,967.03 3,895.14 3,576.30 3,352.38 3,353.81 3,309.44 3,303.39
Total Expenses + 2,581.64 2,639.95 2,616.50 2,515.01 2,586.34 2,586.34 1,733.64
Cost of Materials Consumed 436.15 499.90 545.17 427.48 611.18 472.02 474.38
Employee Benefit Expense 607.25 579.70 624.39 594.99 610.23 614.69 628.55
Other Expenses 554.16 601.29 586.10 567.57 549.73 576.14 630.71
Operating Profit 1,240.03 1,109.26 837.21 736.71 691.69 612.52 1,490.74
OPM % 32.4% 29.6% 24.2% 22.7% 21.1% 19.1% 46.2%
Profit Before Exceptional 1,385.39 1,255.19 959.80 837.37 767.47 723.10 647.24
Exceptional Items 20.62 4.69 -143.61 -0.97 11.58 -172.60 -341.49
Profit Before Tax + 1,406.01 1,259.88 816.19 836.40 779.05 550.50 305.75
Tax Expense 370.03 332.30 226.23 225.71 -915.67 192.35 212.55
Tax % 26.3% 26.4% 27.7% 27% -117.5% 34.9% 69.5%
Profit After Tax 1,035.98 927.58 589.96 610.69 1,694.72 358.15 93.20
EPS (Basic) 54.52 54.52 34.83 36.05 100.04 21.14 5.50

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 539.16 502.19 544.56 618.36 727.64 564.20 0.00
Property, Plant & Equipment 273.51 269.54 296.80 294.81 294.94 340.91 0.00
Capital Work in Progress 32.93 14.32 13.93 20.31 30.50 13.21 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 6.56 13.33 23.55 34.09 34.50 43.36 0.00
Current Assets + 3,784.71 3,605.89 3,012.06 2,708.22 3,905.53 2,369.04 0.00
Inventories 457.55 481.74 525.05 459.97 534.70 546.70 0.00
Trade Receivables 273.11 292.55 222.06 192.38 205.24 215.60 0.00
Cash and Cash Equivalents 1,102.05 538.85 64.17 34.94 286.19 405.19 0.00
Current Investments 1,000.00 1,000.00 813.22 518.29 365.59 0.00 0.00
LIABILITIES & EQUITY
Total Equity 2,284.69 1,951.31 1,777.64 1,741.28 2,662.96 1,499.08 0.00
Equity Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 0.00
Other Equity 2,098.01 1,781.90 1,608.23 1,571.87 2,493.55 1,329.67 0.00
Non-Current Liabilities 260.07 251.60 254.03 258.94 271.89 281.81 0.00
Current Liabilities 1,779.11 1,905.17 1,524.95 1,326.36 1,698.43 1,332.47 0.00
Total Liabilities 2,039.18 2,156.77 1,778.98 1,585.30 1,970.32 1,614.28 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 903.30 1,289.91 582.00 484.23 810.74 577.93 0.00
Cash from Investing Activities 396.98 -45.81 8.72 807.85 -405.50 418.58 0.00
Cash from Financing Activities -737.08 -769.42 -561.49 -1,543.33 -524.24 -696.13 0.00
Net Increase/Decrease in Cash 563.20 474.68 29.23 -251.25 -119.00 300.38 0.00